Brainbow Information

Brainbow is a young start-up based in Rome (Italy) which is developing a novel concept of mental disease analysis through neural network-based algorithms applied to EEG. Around 60% of the EU population suffers from a neurological disease. But many of them are not easy to diagnose. Early diagnosis often times leads to better clinical outcomes. Unfortunately, early diagnosis is still a challenge for many neurological disease, like ASD, Alzheimer’s, Parkinson etc. With this in mind, we have developed an innovative screening method for neurological diseases and disorders based on machine learning analysis of the electroencephalogram (EEG). Thanks to our proprietary neural network-based algorithm, we can support doctors in diagnosis by facilitating early screening of diseases with similar symptoms but pathologically different. We aim to speed up the identification and administration of the problem and thus the most appropriate therapy for the patient. Currently the company is focusing the effort on ASD early-detection, an issue still challenging the medical community, which is eagerly looking for a solution able to make the screening as early and reliable as possible. We believe our software could become a novel key tool for the Neuropsychiatrist and result in a dramatic improvement of the treatment pathway.